youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
EW:NYSE
Edwards Lifesciences Corp
$92.01
arrow_downward
-2.57%(-2.43) 1D
$92.01
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 30, 3:00:09 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$94.55
High
$95.34
Low
$91.87
Mkt. cap
53.03B
Avg. vol.
3.54M
Volume
6.04M
P/E ratio
53.23
52-wk high
$96.29
52-wk low
$74.66
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
Open
$94.55
High
$95.34
Low
$91.87
Mkt. cap
53.03B
Avg. vol.
3.54M
Volume
6.04M
P/E ratio
53.23
52-wk high
$96.29
52-wk low
$74.66
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
News Corp
·
1 day ago
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors
Zacks
·
2 days ago
Edwards' Q3 Earnings on the Horizon: What's in the Cards?
Zacks
·
2 days ago
Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Seeking Alpha
·
3 days ago
Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio Thrives
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com